Back to top

Verrica Pharmaceuticals (VRCA) Reports Robust Growth in YCANTH Sales

Verrica Pharmaceuticals (VRCA) Reports Robust Growth in YCANTH Sales

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Verrica Pharmaceuticals Inc. (VRCA)